Haiwang Biotech announced that due to changes in market conditions, after friendly negotiations, the company's holding subsidiary Henan Haiwang Group plans to sign an “Equity Transfer Agreement” with Henan Huicheng. Henan Haiwang Group will transfer 100% of its shares in Henan Dongsen to Henan Huicheng at a price of 248 million yuan. After the equity transfer was completed, Henan Huicheng held 100% of Henan Dongsen's shares, Henan Haiwang Group no longer held Henan Dongsen's shares, and Henan Dongsen was no longer a subsidiary within the scope of the company's merger.

Haiwang Biotech announced that due to changes in market conditions, after friendly negotiations, the company's holding subsidiary Henan Haiwang Group plans to sign an “Equity Transfer Agreement” with Henan Huicheng. Henan Haiwang Group will transfer 100% of its shares in Henan Dongsen to Henan Huicheng at a price of 248 million yuan. After the equity transfer was completed, Henan Huicheng held 100% of Henan Dongsen's shares, Henan Haiwang Group no longer held Henan Dongsen's shares, and Henan Dongsen was no longer a subsidiary within the scope of the company's merger.